{"id":"W2226426266","doi":"10.1200/jco.2014.32.15_suppl.5008","title":"Phase 3, randomized, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients (pts) with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) (ELM-PC 4 trial)","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Prednisone; Placebo; Chemotherapy; Internal medicine; Oncology; Randomized controlled trial; Clinical trial; Cancer; Urology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001656158,0.001979838,0.003014236,0.000464578,0.0005155376,0.001274272,0.001012926,0.001862424,0.01083433],"category_scores_gemma":[0.001752328,0.0007456057,0.001656471,0.0004115249,0.00111023,0.001070306,0.0003959243,0.003574839,0.001842684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007509617,"about_ca_system_score_gemma":0.001369321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008664304,"about_ca_topic_score_gemma":0.00262092,"domain_scores_codex":[0.9994851,0.0002671095,0.00002775808,0.00009675116,0.00003632316,0.00008685622],"domain_scores_gemma":[0.9992411,0.0002043076,0.000212624,0.00007090722,0.00005420999,0.0002169043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9852384,0.004582323,0.0002784076,0.0004097497,0.0004519686,0.00002588665,0.00002867907,0.0001898513,0.001682483,0.00007436578,0.0006685861,0.006369374],"study_design_scores_gemma":[0.9739878,0.02452673,0.0005605849,0.00001515714,0.0001955315,0.00001672314,0.000008404931,0.0001587201,0.0001707702,0.00008248517,0.0002705292,0.000006661693],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756318,0.004312448,0.001030676,0.0009858432,0.0007709594,0.009954232,0.002853326,0.0004052389,0.004055515],"genre_scores_gemma":[0.9705334,0.002687451,0.002756326,0.002396906,0.0006194916,0.01272558,0.002407231,0.00006002437,0.00581375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01083433,"threshold_uncertainty_score":0.03624445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07938703583573291,"score_gpt":0.4593268820083639,"score_spread":0.379939846172631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}